Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_assertion type Assertion NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_head.
- NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_assertion description "[Cancer cells require nutrients and energy to adapt to increased biosynthetic activity, and protein synthesis inhibition downstream of mammalian target of rapamycin complex 1 (mTORC1) has shown promise as a possible therapy for acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_provenance.
- NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_assertion evidence source_evidence_literature NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_provenance.
- NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_assertion SIO_000772 24014241 NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_provenance.
- NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_assertion wasDerivedFrom befree-2016 NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_provenance.
- NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_assertion wasGeneratedBy ECO_0000203 NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_provenance.